Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
12/11/2003 | US20030229208 Humanized immunoglobulins |
12/11/2003 | US20030229206 Processing albumin via grinding substance to flour, alkaline and protease extractions, heating, precipitation, neutralization and recovery |
12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
12/11/2003 | US20030229021 Antiallergens |
12/11/2003 | US20030228709 Arrays |
12/11/2003 | US20030228696 Novel insect cell line |
12/11/2003 | US20030228673 Novel glucose 6-oxidases |
12/11/2003 | US20030228671 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production |
12/11/2003 | US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders |
12/11/2003 | US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
12/11/2003 | US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening |
12/11/2003 | US20030228657 Methods for enhancing the translation and expression of recombinant proteins |
12/11/2003 | US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2003 | US20030228654 Method for producing antimicrobial protein and fusion protein |
12/11/2003 | US20030228653 Novel orphan cytokine receptor polypeptides |
12/11/2003 | US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer |
12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
12/11/2003 | US20030228593 Ribozymes with broad tRNA aminoacylation activity |
12/11/2003 | US20030228329 Genetic engineering; insertion of gene; generating immunology response |
12/11/2003 | US20030228319 Antitumor agents, anticancer agents |
12/11/2003 | US20030228316 Mitochondrial creatine kinase antibody |
12/11/2003 | US20030228305 Compositions and methods for the diagnosis and treatment of tumor |
12/11/2003 | US20030228303 Antibodies specific for native PrPsc |
12/11/2003 | CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene |
12/11/2003 | CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
12/11/2003 | CA2488539A1 Novel proteins and nucleic acids encoding same |
12/11/2003 | CA2488196A1 Methods and materials for the production of lactic acid in yeast |
12/11/2003 | CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders |
12/11/2003 | CA2487915A1 Allergen from mugwort pollen |
12/11/2003 | CA2487296A1 Methods and materials for the production of d-lactic acid in yeast |
12/11/2003 | CA2487024A1 Control sequences of the human corin gene |
12/10/2003 | EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy |
12/10/2003 | EP1369486A1 Plasmid shuttle vector between escherichia coli and brevibacillus |
12/10/2003 | EP1369483A1 Allergen from mugwort pollen |
12/10/2003 | EP1369481A1 Novel translational activity-promoting higher-order structure |
12/10/2003 | EP1369478A1 Novel scavenger receptor class a protein |
12/10/2003 | EP1369431A1 Anti-hla-dr antibody |
12/10/2003 | EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR |
12/10/2003 | EP1369427A2 HIV-3 retrovirus strains and their use |
12/10/2003 | EP1368659A2 Subunit vaccines with a2 supermotifs |
12/10/2003 | EP1368486A2 Formulations for il-11 |
12/10/2003 | EP1368483A2 Process for production of polypeptides |
12/10/2003 | EP1368477A1 Vaccine |
12/10/2003 | EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii |
12/10/2003 | EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation |
12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
12/10/2003 | EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
12/10/2003 | EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities |
12/10/2003 | EP1368458A2 Interferon-alpha induced gene |
12/10/2003 | EP1368456A2 Anti-bacterial vaccine compositions |
12/10/2003 | EP1368378A2 Constitutively desensitized g protein-coupled receptors |
12/10/2003 | EP1368377A2 Modified interferon beta with reduced immunogenicity |
12/10/2003 | EP1368051A2 Urocortin-iii and uses thereof |
12/10/2003 | EP1367881A2 Plant cell having animal-type sugar chain adding function |
12/10/2003 | EP1123410B1 The enzyme-mediated synthesis of peptidomimetics |
12/10/2003 | EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
12/10/2003 | EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen |
12/10/2003 | EP0824589B1 Utrophin gene promoter |
12/10/2003 | EP0770139B1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE |
12/10/2003 | EP0754059B1 Methods and compositions useful for inhibition of angiogenesis |
12/10/2003 | EP0724641B1 Anti-microbial proteins |
12/10/2003 | EP0724456B1 Antibodies to cd40 |
12/10/2003 | EP0680316B1 Novel parasitic helminth proteins |
12/10/2003 | EP0671920B1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease |
12/10/2003 | EP0666914B1 Novel p-selectin ligand protein |
12/10/2003 | EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
12/10/2003 | CN1461344A Multivalent target binding protein |
12/10/2003 | CN1461343A 多核苷酸 Polynucleotide |
12/10/2003 | CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B |
12/10/2003 | CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using |
12/10/2003 | CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression |
12/10/2003 | CN1460714A Cell activation and adverse-resisting gene inductor and its prepartion method |
12/10/2003 | CN1130463C Fermentation precess by expressing recombined protein in bacillus |
12/10/2003 | CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C |
12/10/2003 | CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders |
12/09/2003 | US6660905 Mice comprising engrafted functional human hepatocytes |
12/09/2003 | US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors |
12/09/2003 | US6660843 Fusion of Fc domains with biologically active peptides |
12/09/2003 | US6660839 Tumor necrosis related receptor, TR7 |
12/09/2003 | US6660834 Reagents useful for detecting diseases of the gastrointestinal tract |
12/09/2003 | US6660523 Propagating preferential nervous system tissues; obtain tissue, incubate with preferential antigens, culture tissue, recover tissue |
12/09/2003 | US6660520 Nrde |
12/09/2003 | US6660512 Human lysozyme gene, it's encoded polypeptide and the method of preparing them |
12/09/2003 | US6660501 Production of proteins by cell culture |
12/09/2003 | US6660499 Nucleic acid encoding human DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma) |
12/09/2003 | US6660490 Nucleotide seqences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders |
12/09/2003 | US6660275 Amplification nucleic acids |
12/09/2003 | US6660274 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
12/09/2003 | US6660271 Ubiquitin fusion-based vaccine system |
12/09/2003 | US6660269 Canine tropical pancytopenia; |
12/09/2003 | US6660263 Mono-chlorinated lipophilic macrocyclic lactone isolated from a strain of Serratia marcescens that produces oocydin A in culture. |
12/09/2003 | US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence |
12/09/2003 | CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using |
12/09/2003 | CA2104110C Nucleic acid fragment from the chromosome x region involved in the fragile x syndrome, nucleotide probe and method for the diagnosis of mental retardation with fragile x |
12/04/2003 | WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions |
12/04/2003 | WO2003100022A2 Methods and dna constructs for high yield production of polypeptides |